Sex-dimorphic tumor growth is regulated by tumor microenvironmental and systemic signals

Xianfeng Wang1, Hongcun Bao1, Yi-Chun Huang1

  • 1Department of Biochemistry and Molecular Biology, Tulane University School of Medicine, Louisiana Cancer Research Center, New Orleans, LA 70112, USA.

Science Advances
|December 6, 2024
PubMed

Insights

Female fruit flies show faster tumor growth due to complex communication between tumor cells, immune cells, and insulin-producing cells. This interaction involves specific signaling pathways that regulate growth differently between sexes.

Area of Science:

  • Developmental Biology
  • Cancer Biology
  • Endocrinology

Background:

  • Tumor growth is regulated by complex signals, with notable sex-based differences.
  • Mechanisms underlying tumor signal integration and sexual dimorphism are poorly understood.

Purpose of the Study:

  • To investigate the mechanisms controlling sexually dimorphic tumor growth.
  • To elucidate the communication pathways between tumor cells, immune cells, and endocrine cells in a Drosophila model.

Main Methods:

  • Utilized a Drosophila tumor model derived from non-reproductive tissue.
  • Analyzed intercellular communication involving Notch, TNF-α homolog Eiger, JNK pathway, cytokine Upd2, and Drosophila insulin-like peptide 2 (Dilp2).

Main Results:

  • Female-biased tumor growth was observed, driven by tumor cell-hemocyte-IPC interactions.
  • Notch-active tumor cells recruit hemocytes, leading to JNK activation and Upd2 up-regulation.
  • Upd2 modulates Dilp2 release, which activates insulin signaling, promoting sex-specific tumor growth.

Conclusions:

  • A novel relay mechanism involving the tumor microenvironment and systemic signals controls tumor growth sexual dimorphism.
  • This study reveals a complex interplay of signaling pathways contributing to sex-based differences in tumor progression.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K